Table 2.
Complication | Therapy | |
---|---|---|
Pain | Mild to moderate | Codeine with acetaminophen or aspirin
|
Moderate to severe | Morphine sulfate immediate-release (MSIR)
|
|
Infection | Fever without a source (rule out sepsis) |
Empirical therapy coverage for: Streptococcus pneumoniae, Salmonella, Haemophilus influenzae, gram-negative enterics |
Meningitis | Streptococcus pneumoniae, Neisseria meningitides, H. influenzae | |
Chest syndrome | S. pneumoniae, Legionella, Mycoplasma pneumoniae, respiratory syncytial virus, Chlamydia pneumoniae | |
Osteomyelitis/septic arthritis | Salmonella, Staphylococcus aureus, S. pneumoniae | |
Urinary tract infection | Escherichia coli, other gram-negative enterics |
IV = intravenously.
From National Institutes of Health. The Management of Sickle Cell Disease, 4th ed. revised, June 2002.22